Quantum-Si incorporated (QSI)

NASDAQ: QSI · IEX Real-Time Price · USD
1.51
+0.02 (1.34%)
At close: Nov 28, 2023, 4:00 PM
1.53
+0.02 (1.32%)
After-hours: Nov 28, 2023, 4:40 PM EST

Company Description

Quantum-Si incorporated, a life sciences company, engages in the development of protein detection platform to enable Next Generation Protein Sequencing (NGPS).

The company's platform is comprised of the Carbon automated sample preparation instrument; the Platinum single-molecule detection and NGPS instrument with Time-Domain Sequencing chip; the Quantum-Si Cloud data analysis software; and reagent kits for use with its instruments.

The company was founded in 2013 is based in Guilford, Connecticut.

Quantum-Si incorporated
Quantum-Si incorporated logo
Country United States
Founded 2013
Industry Biotechnology
Sector Healthcare
Employees 196
CEO Jeffrey Alan Hawkins

Contact Details

Address:
29 Business Park Drive
Branford, Connecticut 06405
United States
Phone (203) 458-7100
Website quantum-si.com

Stock Details

Ticker Symbol QSI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001816431
CUSIP Number 74765K105
ISIN Number US74765K1051
Employer ID 85-1388175
SIC Code 3829

Key Executives

Name Position
Dr. Jonathan M. Rothberg Ph.D. Founder and Executive Chairman
Claudia Napal Drayton Chief Financial Officer
Dr. Christian Lapointe J.D., Ph.D. General Counsel and Corporate Secretary
Dr. Michael P. McKenna Ph.D. Executive Vice President of Product Development and Operations
Jeffrey Alan Hawkins Chief Executive Officer and Director
Dr. Patrick Schneider Ph.D. President and Chief Operating Officer
Todd Rearick Chief Technology Officer
Juan Esteban Avendano Vice President of Investor Relations

Latest SEC Filings

Date Type Title
Nov 9, 2023 10-Q Quarterly Report
Nov 9, 2023 8-K Current Report
Sep 21, 2023 8-K Current Report
Sep 13, 2023 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Sep 5, 2023 8-K Current Report
Aug 29, 2023 8-K Current Report
Aug 22, 2023 EFFECT Notice of Effectiveness
Aug 11, 2023 S-3 Registration statement under Securities Act of 1933
Aug 7, 2023 10-Q Quarterly Report
Aug 7, 2023 8-K Current Report